“Exogenous Glutamate Oxalacetate Transaminase 1 (GOT1) as a new treatment for Amyotrophic Lateral Sclerosis (ALS): Developing preclinical study”
by Lucía del Pozo Filíu
Download the program of the day here
To follow it online you can do so through the link
